Optimisation and Performance of Reduced Preparation CT Colography
NCT ID: NCT00212433
Last Updated: 2025-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
120 participants
INTERVENTIONAL
2004-07-31
2006-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Autologous Blood Marker Localization in Laparoscopic Colorectal Cancer Surgery
NCT05597384
Colonography Versus Colonoscopy in High Risk Patient
NCT00748449
CITRuS Stage 1; Feasibility
NCT04697394
Endoscopic Visualisation of Anastomosis in Colorectal Cancer Surgery
NCT04738240
Long-term Outcomes of Colonic Stent as a "Bridge to Surgery" for Malignant Large-bowel Obstruction
NCT04111042
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Interest has been generated in the use of orally ingested dilute barium or ionated contrast medium prior ro CT colonography to "label" or "tag" residual fluid or faecal matter reduced laxative. Such oral contrast agents are highly attenuating to X-rays such that labeled residual bowel contents appear white on CT scanning and are readily distinguished from true colonic pathology.
Despite the early promise of a few limited studies, there is no consensus as to the optimum oral contrast type, dose and concentration. Anecdotally barium tends to best label solid residue whereas iodinated contrast best labels fluid, but this assumption has not been proven. Furthermore it is known that iodinated contrast tends to draw fluid into the bowel, producing a wet colon, which may not be suited to CT colonography. However, this indrawing of fluid by iodinated contrast such as gastrograffin produces a mild laxative effect, which may obviate the need for further formal purgation.
The study aims to establish the optimum reduced preparation-tagging regimen, establish patient experience and document diagnostic performance compared to conventional colonoscopy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tagitol V, Lo So, Readi-Cat 2
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Symptomatic patients eg. change in bowel habit, rectal bleeding etc.
2. Polyp surveillance
3. Strong family history
4. suspected neoplasia on previous investigation (e.g. barium enema)
Exclusion Criteria
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St Mark's Foundation
UNKNOWN
London North West Healthcare NHS Trust
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stuart Taylor, MD
Role: PRINCIPAL_INVESTIGATOR
St Mark's Hospital, North West London NHS Trust; & University College Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St Mark's Hospital, North West London Hospitals NHS Trust
London, Middlesex, United Kingdom
University College Hospital
London, , United Kingdom
Oxford Radcliffe Hospital NHS Trust
Oxford, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
04/Q0405/CT2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.